Achieve Emotional Balance: A Special Blend of Saffron and Melon Extract In today’s high-impulse, fast-paced society, individuals are faced with higher levels of stress, chronic fatigue, poor quality of sleep, and increasing rates of depression and anxiety. As a result, people have sought different ways to improve their mood and increase energy so that they can fully enjoy their lives. Millions of men and women have sought pharmaceutical remedies in an attempt to restore emotional balance. These often include one or more anti-depressants, anti-anxiety medications, and/or pain relievers. Many individuals are wary of taking such medications due to their negative side effects and fear of dependence or addiction. The good news is there is scientific evidence that supports the case for alternative solutions. Two extremely promising ingredients have each gained the attention of researchers for their potential to achieve stress reduction, reduce feelings of depression and anxiety, and improve cognitive function. These two key ingredients (saffron and extract from the Cucumis Melo L. melon, which is a special French variety of cantaloupe), have been specifically combined to deliver a unique product for enhanced mood and emotional balance. Saffron Extract for Treatment of Depression and Anxiety Saffron has long been part of the culinary world. This spice is famous for giving dishes a distinctive color, fragrant aroma, and a unique flavor. However, it is saffron’s medicinal value that is making its flower (Crocus Sativus) more valuable than ever before. Saffron has multiple medicinal properties and has been used in traditional Persian culture for centuries as a treatment for depression ( Shahin et al., 2005 ). It has only been relatively recently that research has caught up to tradition and offered scientific evidence to support the healing claims long attributed to this herb. Saffron extract, by all accounts, is a mood enhancer and has shown great promise as a natural alternative to anti-depressants. For example, one study was conducted with 40 adults who had been diagnosed with major depression. Within this double ‐ blind, placebo ‐ controlled, single- center clinical trial , these individuals were randomly split into two groups. Over the course of 6

Made with FlippingBook Annual report